Discover how Geneo, Singapore's new life sciences hub, is bridging companies with talent and fostering vital collaboration ...

Tiziana Life Sciences Ltd (NASDAQ:TLSA) has completed enrollment in its Phase 2 clinical trial evaluating foralumab for ...

Gilead acquired all outstanding equity of Tubulis for $3.15bn upfront, plus up to $1.85bn in milestone payments.

From today's D.C. Circuit decision in Butters v. Nat'l Acad. of Sciences, by Judge Douglas Ginsburg, joined by Judges ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of its previously announced acquisition of Tubulis GmbH, a private Germany-based, clinical-stage biotechnology company ...

Gilead acquired all outstanding equity of Tubulis for $3.15bn upfront, plus up to $1.85bn in milestone payments.

Strong Buy on WVE-N531 and WVE-006 catalysts, Phase data, and cash runway into 2028. Click for this WVE stock update.

This clinical-stage biotech develops innovative retinal disease therapies, with its lead candidate advancing through ...

The Department of Nutrition Sciences at Qatar University (QU)’s College of Health Sciences organised the annual “Smart Start” ...

A new S$1.4 billion biomedical sciences hub will house Singapore's public R&D agency A*STAR and some of the world's leading biomedical firms. The space, called Geneo, comes as Singapore has committed ...

As one of the most popular and widespread gambling games of all time, poker continues to awe and inspire people all over the ...

Innosphere’s 2026 Life Sciences Incubator will feature a cohort of 38 startups from nine states and three countries.